WallStSmart

Yuanbao Inc. American Depositary Shares (YB)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Yuanbao Inc. American Depositary Shares generates 1589% more annual revenue ($4.37B vs $258.90M). YB leads profitability with a 29.9% profit margin vs -15.5%. YB earns a higher WallStSmart Score of 78/100 (B+).

YB

Strong Buy

78

out of 100

Grade: B+

Growth: 10.0Profit: 10.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for YB.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

YB6 strengths · Avg: 9.5/10
P/E RatioValuation
4.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
50.9%10/10

Every $100 of equity generates 51 in profit

Operating MarginProfitability
33.6%10/10

Strong operational efficiency at 33.6%

Revenue GrowthGrowth
32.2%10/10

Revenue surging 32.2% year-over-year

Profit MarginProfitability
29.9%9/10

Keeps 30 of every $100 in revenue as profit

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

YB1 concerns · Avg: 3.0/10
Market CapQuality
$753.41M3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : YB

The strongest argument for YB centers on P/E Ratio, Return on Equity, Operating Margin. Profitability is solid with margins at 29.9% and operating margin at 33.6%. Revenue growth of 32.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : YB

The primary concerns for YB are Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

YB profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

YB scores higher overall (78/100 vs 41/100), backed by strong 29.9% margins and 32.2% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Yuanbao Inc. American Depositary Shares

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Yuanbao Inc., provides online insurance distribution and services in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?